Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Regulartory effect of HNRNPL and LARP on circular RNA expression in LNCaP prostate cancer cells

PROVIDER: PRJNA295189 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR2318063_1.fastq.gz	Fastqsanger.gz
	SRR2318063_2.fastq.gz	Fastqsanger.gz
	SRR2318064_1.fastq.gz	Fastqsanger.gz
	SRR2318064_2.fastq.gz	Fastqsanger.gz
	SRR2318065_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Regulartory effect of HNRNPL and LARP on circular RNA expression in LNCaP prostate cancer cells

Project description:Analysis of circular RNA expression in LNCaP prostate cancer cells treated with different siRNAs to define the regulatory effect of HNRNPL and LARP on circular RNA expression.

2017-09-28 | GSE72840 | GEO

Homo sapiens

Project description:HNRNPL RIP-seq in LNCaP prostate cancer cells

| PRJNA295188 | ENA

Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells

Project description:Analysis of RNA expression in LNCaP prostate cancer cells treated with different siRNAs to define the regulatory effect of HNRNPL and LARP on RNA expression.

2017-09-28 | GSE72842 | GEO

Homo sapiens

Project description:Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells

| PRJNA295183 | ENA

Homo sapiens

Project description:FOXO4 knockdown in LNCaP prostate cancer cells

| PRJNA252505 | ENA

Homo sapiens

Project description:CRISPR screen in LNCaP prostate cancer cells

| PRJNA295182 | ENA

Homo sapiens

Project description:REST knockdown in LNCaP prostate cancer cells

| PRJNA223238 | ENA

Homo sapiens

Project description:50uM Casodex treatment of LNCaP Prostate Cancer cells

| PRJNA101667 | ENA

Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells

Project description:Prostate cancer is the most common cancer in men and cardiac glycosides inhibit prostate cancer cell proliferation. In order to investigate the mechanism by which cardiac glycosides inhibit prostate cancer cells, we observed genome-wide RNA expression in prostate cancer LNCaP-abl cells, hormone resistant cells, after the cardiac glycoside treatment using RNA-Seq. In addition, we profiled LNCaP-abl cells after androgen receptor (AR) knockdown to observe whether cardiac glycoside effect on RNA expression is similar to that of AR knockdown.

2012-04-04 | GSE35126 | GEO

Homo sapiens

Project description:The cistrome of NKX3.1 in LNCaP prostate cancer cells

| PRJNA173399 | ENA